Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyDevoted Health Cardiac CRT Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentDevoted HealthPolicy UMGT.CL.0057

    Cardiac Resynchronization Therapy (CRT) Coverage

    Customize your policy alerts

    Sign up for devoted_health Policy UMGT.CL.0057 alerts

    Get alerted when Policy UMGT.CL.0057 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of cardiac resynchronization therapy for Devoted Health Medicare Advantage members in listed MAC jurisdictions when no applicable LCD exists. CRT is covered when members meet the applicable clinical criteria for systolic heart failure or specified conduction and pacing abnormalities.

    Policy Summary
    PayerDevoted Health
    PolicyCardiac Resynchronization Therapy (CRT) Coverage
    Policy CodePolicy UMGT.CL.0057
    Change TypeNo material clinical or coverage changes
    Effective DateApril 23, 2026
    Next Review DateApril 15, 2027
    Key ActionDocument the applicable CRT scenario and all corresponding requirements, including ejection fraction, NYHA class, QRS duration, conduction abnormality or pacing status, heart failure symptoms, and an FDA-approved CRT device where specified.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4Distinct clinical coverage scenarios
    ≤35%LVEF threshold for first scenario
    ≥150 msQRS threshold with cardiomyopathy
    >40%RV pacing threshold in paced patients

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2Applicable CRT procedure codes

    Cardiac Resynchronization Therapy Coverage Criteria

    LVEF ≤35% with dyssynchronous ventricular activation

    CRT is medically necessary when the member has systolic heart failure and dyssynchronous ventricular activation and meets all criteria for one clinical scenario.

    LVEF cardiomyopathy pathway

    • Cardiomyopathy branch

      • Ischemic or non-ischemic cardiomyopathy: Clinical documentation indicates ischemic or non-ischemic cardiomyopathy, NYHA class III or ambulatory class IV heart failure, QRS at least 150 ms, and any type of bundle branch block with evidence of dyssynchrony.QRS ≥150 ms

        All four elements are required.

      • No ischemic or non-ischemic cardiomyopathy: Clinical documentation indicates no diagnosis of ischemic or non-ischemic cardiomyopathy, NYHA class II, III, or ambulatory class IV heart failure, QRS 130 ms or more, and left bundle branch block.QRS ≥130 ms

        All four elements are required.

    Second- or third-degree atrioventricular block

    Covered when all listed criteria are met.

    Second- or third-degree AV block: Member has second- or third-degree atrioventricular block, ejection fraction less than 50%, NYHA class I, II, or III heart failure, anticipated frequent ventricular pacing, and an FDA-approved CRT device.Ejection fraction <50%

    All five elements are required.

    First-degree block

    Covered when all listed criteria are met.

    First-degree block: Member has first-degree block, PR interval greater than 300 ms, ejection fraction less than 50%, NYHA class I, II, or III heart failure, anticipated frequent ventricular pacing, and an FDA-approved CRT device.PR interval >300 ms; ejection fraction <50%

    All six elements are required.

    Worsening heart failure in currently paced patient

    Covered when all listed criteria are met.

    Worsening heart failure in currently paced patient: Member has left ventricular ejection fraction less than 40%, right ventricular pacing occurring frequently at greater than 40% of the time, worsening heart failure symptoms classified as NYHA class II-IV, and an FDA-approved CRT device.LVEF <40%; RV pacing >40% of the time

    All four elements are required.

    Coding and Clinical Thresholds

    Applicable CPT CodesCPTCovered
    33224Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, with attachment to previously placed pacemaker or implantable defibrillator pulse generator (including revision of pocket, removal, insertion, and/or replacement of existing generator)
    33225Insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) (list separately in addition to code for primary procedure)
    Cardiomyopathy pathway
    ThresholdLeft ventricular ejection fraction (LVEF) ≤35%
    Applicable pathwayCardiomyopathy with dyssynchronous ventricular activation
    Additional requirementMember must meet one of the two cardiomyopathy branches
    Cardiomyopathy with ischemic or non-ischemic cardiomyopathy
    ThresholdQRS duration ≥150 ms
    Heart failure classNYHA class III or ambulatory class IV heart failure
    Additional requirement

    Documentation and Denial Risks

    Documentation Required

    Document All Applicable CRT Criteria

    Document all applicable clinical criteria and supporting records for CRT. CRT is medically necessary only when the member has systolic heart failure with dyssynchronous ventricular activation and meets every requirement for at least one applicable clinical scenario.

    • LVEF ≤35% with ischemic or non-ischemic cardiomyopathy: NYHA class III or ambulatory class IV heart failure, QRS ≥150 ms, and any type of bundle branch block with evidence of dyssynchrony.
    • LVEF ≤35% without ischemic or non-ischemic cardiomyopathy: NYHA class II, III, or ambulatory class IV heart failure, QRS ≥130 ms, and left bundle branch block (LBBB).
    • Second- or third-degree AV block: ejection fraction <50%, NYHA class I, II, or III, anticipated frequent ventricular pacing, and an FDA-approved CRT device.
    • First-degree block: PR interval >300 ms, ejection fraction <50%, NYHA class I, II, or III, anticipated frequent ventricular pacing, and an FDA-approved CRT device.
    • Worsening heart failure in a currently paced patient: LVEF <40%, frequent RV pacing (>40% of the time), worsening heart failure symptoms (NYHA class II–IV), and an FDA-approved CRT device.

    About Cardiac Resynchronization Therapy

    Cardiac resynchronization therapy (CRT) is used to treat some types of heart failure in which the walls of the left ventricle do not contract at the same time. CRT uses a biventricular pacemaker to deliver electrical signals that coordinate left-ventricular contraction. This policy outlines coverage for CRT and bases its clinical criteria on the evidence reviewed in LCD L39080.

    Policy Terms

    CMS
    AbbreviationCMS
    DefinitionCenters for Medicare and Medicaid Services
    Definitions sectionAcronyms and Definitions
    LCD
    AbbreviationLCD
    DefinitionLocal Coverage Determinations
    Definitions sectionAcronyms and Definitions
    Policy Summary
    PayerDevoted Health
    PolicyCardiac Resynchronization Therapy (CRT) Coverage
    Policy CodePolicy UMGT.CL.0057
    Change TypeNo material clinical or coverage changes
    Effective DateApril 23, 2026
    Next Review DateApril 15, 2027
    Key ActionDocument the applicable CRT scenario and all corresponding requirements, including ejection fraction, NYHA class, QRS duration, conduction abnormality or pacing status, heart failure symptoms, and an FDA-approved CRT device where specified.
    SourceLink
    On This Page
    Cardiac Resynchronization Therapy Coverage CriteriaCoding and Clinical ThresholdsDocumentation and Denial RisksAbout Cardiac Resynchronization TherapyPolicy Terms
    Any type of bundle branch block with evidence of dyssynchrony
    Without ischemic or non-ischemic cardiomyopathy
    ThresholdQRS duration ≥130 ms
    Heart failure classNYHA class II, III, or ambulatory class IV heart failure
    Additional requirementLeft bundle branch block (LBBB)
    Second- or third-degree AV block
    ThresholdEjection fraction <50%
    Conduction abnormalitySecond- or third-degree atrioventricular (AV) block
    Additional requirementAnticipated frequent ventricular pacing
    First-degree block
    ThresholdPR interval >300 ms
    Conduction abnormalityFirst-degree block
    Additional requirementEjection fraction <50%
    First-degree block
    ThresholdEjection fraction <50%
    Conduction abnormalityFirst-degree block
    Additional requirementAnticipated frequent ventricular pacing
    Worsening heart failure in currently paced patient
    ThresholdLeft ventricular ejection fraction (LVEF) <40%
    Heart failure statusWorsening heart failure symptoms classified as NYHA class II-IV
    Additional requirementFDA-approved CRT device
    Worsening heart failure in currently paced patient
    ThresholdRight ventricular (RV) pacing >40% of the time
    Heart failure statusWorsening heart failure symptoms classified as NYHA class II-IV
    Additional requirementLeft ventricular ejection fraction (LVEF) <40%
    Denial Risk

    Failure to Meet an Approved Clinical Scenario

    CRT may be denied when the member does not satisfy all required criteria for at least one of the four approved clinical scenarios. Documentation must establish the applicable scenario and every associated threshold or condition.

    • LVEF ≤35% pathway with ischemic or non-ischemic cardiomyopathy
    • LVEF ≤35% pathway without ischemic or non-ischemic cardiomyopathy
    • Second- or third-degree AV block
    • First-degree block
    • Worsening heart failure in a currently paced patient
    Denial Risk

    Missing Cardiomyopathy Criteria

    For an LVEF ≤35% CRT pathway, denial risk applies when documentation is missing or does not support the required cardiomyopathy status, QRS duration, conduction abnormality, dyssynchrony, or NYHA functional class criteria.

    • With ischemic or non-ischemic cardiomyopathy: NYHA class III or ambulatory class IV, QRS ≥150 ms, and any type of bundle branch block with evidence of dyssynchrony are all required.
    • Without ischemic or non-ischemic cardiomyopathy: NYHA class II, III, or ambulatory class IV, QRS ≥130 ms, and LBBB are all required.
    Denial Risk

    FDA-Approved CRT Device Requirement

    For the AV block and worsening-heart-failure pathways, denial risk applies when the applicable requirement for an FDA-approved CRT device is not satisfied or documented. This device requirement applies to second- or third-degree AV block, first-degree block, and worsening heart failure in a currently paced patient; it is not listed as a requirement for the LVEF ≤35% pathways.

    • Second- or third-degree AV block: FDA-approved CRT device required.
    • First-degree block: FDA-approved CRT device required.
    • Worsening heart failure in a currently paced patient: FDA-approved CRT device required.
    NCD
    AbbreviationNCD
    DefinitionNational Coverage Determination
    Definitions sectionAcronyms and Definitions
    UM
    AbbreviationUM
    DefinitionUtilization Management
    Definitions sectionAcronyms and Definitions